APO 117 (Terazosin 5 mg)

Pill imprint APO 117 has been identified as Terazosin hydrochloride 5 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO 117

Terazosin hydrochloride 5 mg APO 117 Front
Terazosin hydrochloride 5 mg APO 117 Back
Terazosin hydrochloride 5 mg APO 117
Terazosin hydrochloride 5 mg APO 117
Terazosin hydrochloride
Imprint:
APO
117
Strength:
5 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0117
Inactive Ingredients:
lactose monohydrate
corn starch
stearic acid
magnesium silicate
ammonia
ferrosoferric oxide
potassium hydroxide
propylene glycol
shellac
D&C Red No. 28
FD&C Red No. 40
gelatin
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-5652 Major Pharmaceuticals
23490-6814 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)